Literature DB >> 20187843

Prostatic diseases in the senescence: structural and proliferative features.

Amanda C Hetzl1, Wagner J Favaro, Athanase Billis, Ubirajara Ferreira, Valéria H A Cagnon.   

Abstract

Senescence is one of the main aetiological factors which are responsible for natural androgen ablation in men and occurrence of prostatic diseases. However, it is unclear how the prostatic lesions are signallised in the prostate. Thus, the aim of this study is to characterise the structural, the ultrastructural and the proliferative aspects of the peripheral prostatic zone in the elderly men with and without diagnoses of prostatic lesions and with potential precursors of prostate cancer. Sixty samples of prostatic tissue, from 60 to 90-year-old patients with and without lesions obtained from autopsied or prostatectomised patients were divided into four groups (15 samples per group): standard group (no lesions), benign prostatic hyper-plasia group, high-grade prostatic intra-epithelial neoplasia group and prostatic carcinoma group. The samples were submitted to morphometrical, structural and ultrastructural analyses in addition to cellular apoptosis and proliferative analyses. The results showed morphological damages in the stroma and cellular organelles involved in the secretory process of the prostate. Moreover, the prostatic lesions in elderly men demonstrated disturbance in the proliferation/apoptosis rate, indicating a prevalence of the proliferative process. Finally, the imbalance in prostatic stroma-epithelium interaction was a harmful feature in the elderly men as a result of structural changes, which are crucial factors for the development and progression of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187843     DOI: 10.3109/13685531003586991

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  2 in total

1.  Parental High-Fat Diet Promotes Inflammatory and Senescence-Related Changes in Prostate.

Authors:  Kulbhushan Tikoo; Ajit Vikram; Shweta Shrivastava; Gopabandhu Jena; Heta Shah; Richa Chhabra
Journal:  Oxid Med Cell Longev       Date:  2017-02-05       Impact factor: 6.543

2.  Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients.

Authors:  George Awuku Asare; Sabina Ekua Andam; Henry Asare-Anane; Seth Ammanquah; Yvonne Anang-Quartey; Daniel K Afriyie; Iddis Musah
Journal:  Prostate Int       Date:  2017-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.